Trial · NCT04734197
Adverse events56
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 56
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Conjuctival hyperaemia, study eye and/or fellow eye | Eye disorders | SURF-100 | 3 | 52 | 4 |
| other | Conjuctival hyperaemia, study eye and/or fellow eye | Eye disorders | Mycophenolic Acid 0.1% | 7 | 50 | 8 |
| other | Conjuctival hyperaemia, study eye and/or fellow eye | Eye disorders | Mycophenolic Acid 0.3% | 4 | 50 | 6 |
| other | Conjuctival hyperaemia, study eye and/or fellow eye | Eye disorders | Betamethasone Sodium Phosphate 0.01% | 3 | 49 | 4 |
| other | Conjuctival hyperaemia, study eye and/or fellow eye | Eye disorders | Placebo Comparator: Vehicle | 6 | 47 | 9 |
| other | Conjuctival hyperaemia, study eye and/or fellow eye | Eye disorders | Cyclosporine 0.05% Ophthalmic Emulsion | 3 | 47 | 4 |
| other | Conjuctival hyperaemia, study eye and/or fellow eye | Eye disorders | Lifitegrast 5% Ophthalmic Solution | 0 | 54 | 0 |
| other | Vision blurred, study eye and/or fellow eye | Eye disorders | SURF-100 | 0 | 52 | 0 |
| other | Vision blurred, study eye and/or fellow eye | Eye disorders | Mycophenolic Acid 0.1% | 0 | 50 | 0 |
| other | Vision blurred, study eye and/or fellow eye | Eye disorders | Mycophenolic Acid 0.3% | 0 | 50 | 0 |
| other | Vision blurred, study eye and/or fellow eye | Eye disorders | Betamethasone Sodium Phosphate 0.01% | 0 | 49 | 0 |
| other | Vision blurred, study eye and/or fellow eye | Eye disorders | Placebo Comparator: Vehicle | 0 | 47 | 0 |
| other | Vision blurred, study eye and/or fellow eye | Eye disorders | Cyclosporine 0.05% Ophthalmic Emulsion | 0 | 47 | 0 |
| other | Vision blurred, study eye and/or fellow eye | Eye disorders | Lifitegrast 5% Ophthalmic Solution | 10 | 54 | 12 |
| other | Instillation site pain, study eye and/or fellow eye | General disorders | SURF-100 | 7 | 52 | 11 |
| other | Instillation site pain, study eye and/or fellow eye | General disorders | Mycophenolic Acid 0.1% | 3 | 50 | 4 |
| other | Instillation site pain, study eye and/or fellow eye | General disorders | Mycophenolic Acid 0.3% | 5 | 50 | 5 |
| other | Instillation site pain, study eye and/or fellow eye | General disorders | Betamethasone Sodium Phosphate 0.01% | 0 | 49 | 0 |
| other | Instillation site pain, study eye and/or fellow eye | General disorders | Placebo Comparator: Vehicle | 0 | 47 | 0 |
| other | Instillation site pain, study eye and/or fellow eye | General disorders | Cyclosporine 0.05% Ophthalmic Emulsion | 3 | 47 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04734197/events